Previous close | 0.4197 |
Open | 0.4450 |
Bid | 0.0000 x 3100 |
Ask | 0.0000 x 1100 |
Day's range | 0.4101 - 0.4450 |
52-week range | 0.3500 - 14.5000 |
Volume | |
Avg. volume | 642,052 |
Market cap | 3.045M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.7200 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 7.00 |
TC Biopharm (Holdings) ( NASDAQ:TCBP ) Full Year 2022 Results Key Financial Results Revenue: UK£3.84m (up 94% from FY...
EDINBURGH, Scotland, April 19, 2023 (GLOBE NEWSWIRE) -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, is proud to announce its participation at the upcoming Sequire Investor Summit. This highly anticipated event, scheduled for April 24-26, 2023 at La Concha Resort in San Juan, Puerto Rico, promises to offer an array of exciting opportunities for funds, compa
A look at the shareholders of TC Biopharm (Holdings) Plc ( NASDAQ:TCBP ) can tell us which group is most powerful. We...